Aydin Huseynov
Stock Analyst at Ladenburg Thalmann
(0.80)
# 2,715
Out of 4,479 analysts
58
Total ratings
26.83%
Success rate
-27.11%
Average return
Main Sectors:
Top Industries:
34 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLDI Calidi Biotherapeutics | Initiates: Buy | $1 | $0.20 | +394.07% | 1 | Jun 27, 2024 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $24 → $25 | $4.72 | +429.66% | 2 | May 14, 2024 | |
| MRKR Marker Therapeutics | Initiates: Buy | $11 | $5.24 | +109.92% | 1 | Apr 30, 2024 | |
| ACRV Acrivon Therapeutics | Downgrades: Neutral | n/a | $6.08 | - | 2 | Apr 29, 2024 | |
| ALRN Aileron Therapeutics | Maintains: Buy | $9 → $19 | $2.76 | +588.41% | 2 | Apr 18, 2024 | |
| SPRB Spruce Biosciences | Downgrades: Neutral | n/a | $0.53 | - | 3 | Mar 14, 2024 | |
| BDRX Biodexa Pharmaceuticals | Initiates: Buy | $8 | $0.90 | +791.96% | 1 | Feb 8, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $7 | $1.57 | +345.86% | 1 | Dec 27, 2023 | |
| ZURA Zura Bio | Initiates: Buy | $10 | $3.43 | +191.55% | 1 | Oct 10, 2023 | |
| COEP Coeptis Therapeutics | Initiates: Buy | $3 | $0.28 | +990.91% | 1 | Sep 22, 2023 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $10 → $6 | $1.82 | +229.67% | 2 | Aug 14, 2023 | |
| ATHE Alterity Therapeutics | Maintains: Buy | $20 → $10 | $1.81 | +452.49% | 3 | Jun 5, 2023 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | $4 → $10 | $1.78 | +461.80% | 2 | May 30, 2023 | |
| PALI Palisade Bio | Maintains: Buy | $375 → $240 | $4.54 | +5,186.34% | 2 | May 16, 2023 | |
| TPST Tempest Therapeutics | Maintains: Buy | $8 → $14 | $2.12 | +560.38% | 2 | Apr 28, 2023 | |
| PCSA Processa Pharmaceuticals | Maintains: Speculative Buy | $180 → $80 | $1.93 | +4,045.08% | 1 | Apr 4, 2023 | |
| ADVM Adverum Biotechnologies | Initiates: Buy | $20 | $6.84 | +192.40% | 1 | Mar 7, 2023 | |
| NRBO NeuroBo Pharmaceuticals | Initiates: Buy | $48 | $4.68 | +925.64% | 1 | Dec 7, 2022 | |
| CALA Calithera Biosciences | Downgrades: Neutral | n/a | $0.01 | - | 2 | Nov 15, 2022 | |
| NXTC NextCure | Downgrades: Neutral | n/a | $1.50 | - | 4 | Nov 4, 2022 | |
| ALLR Allarity Therapeutics | Downgrades: Neutral | n/a | $0.22 | - | 2 | Aug 23, 2022 | |
| ANEB Anebulo Pharmaceuticals | Initiates: Buy | $6 | $2.49 | +140.96% | 1 | Jul 27, 2022 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $21 | $6.51 | +222.58% | 1 | Jul 13, 2022 | |
| QNRX Quoin Pharmaceuticals | Initiates: Buy | $300 | $0.58 | +51,929.14% | 1 | May 6, 2022 | |
| ANVS Annovis Bio | Initiates: Buy | $37 | $9.28 | +298.71% | 1 | May 2, 2022 | |
| CMPX Compass Therapeutics | Initiates: Buy | $7 | $0.88 | +695.45% | 1 | Mar 15, 2022 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | n/a | $1.17 | - | 3 | Nov 8, 2021 | |
| REGN Regeneron Pharmaceuticals | Downgrades: Hold | n/a | $1,044.66 | - | 6 | Nov 5, 2021 | |
| INCY Incyte | Upgrades: Buy | n/a | $59.02 | - | 2 | Jul 20, 2021 | |
| SCPS Scopus BioPharma | Initiates: Speculative Buy | n/a | $0.00 | - | 1 | Feb 16, 2021 | |
| NBIX Neurocrine Biosciences | Initiates: Hold | n/a | $137.49 | - | 1 | Sep 30, 2020 | |
| SLRX Salarius Pharmaceuticals | Initiates: Speculative Buy | $1,000 | $2.20 | +45,354.55% | 1 | Jun 16, 2020 | |
| INO Inovio Pharmaceuticals | Initiates: Buy | $336 | $8.43 | +3,885.77% | 1 | May 21, 2020 | |
| VYGR Voyager Therapeutics | Initiates: Buy | n/a | $7.59 | - | 1 | Mar 19, 2020 |
Calidi Biotherapeutics
Jun 27, 2024
Initiates: Buy
Price Target: $1
Current: $0.20
Upside: +394.07%
Capricor Therapeutics
May 14, 2024
Maintains: Buy
Price Target: $24 → $25
Current: $4.72
Upside: +429.66%
Marker Therapeutics
Apr 30, 2024
Initiates: Buy
Price Target: $11
Current: $5.24
Upside: +109.92%
Acrivon Therapeutics
Apr 29, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.08
Upside: -
Aileron Therapeutics
Apr 18, 2024
Maintains: Buy
Price Target: $9 → $19
Current: $2.76
Upside: +588.41%
Spruce Biosciences
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.53
Upside: -
Biodexa Pharmaceuticals
Feb 8, 2024
Initiates: Buy
Price Target: $8
Current: $0.90
Upside: +791.96%
PMV Pharmaceuticals
Dec 27, 2023
Initiates: Buy
Price Target: $7
Current: $1.57
Upside: +345.86%
Zura Bio
Oct 10, 2023
Initiates: Buy
Price Target: $10
Current: $3.43
Upside: +191.55%
Coeptis Therapeutics
Sep 22, 2023
Initiates: Buy
Price Target: $3
Current: $0.28
Upside: +990.91%
Cognition Therapeutics
Aug 14, 2023
Maintains: Buy
Price Target: $10 → $6
Current: $1.82
Upside: +229.67%
Alterity Therapeutics
Jun 5, 2023
Maintains: Buy
Price Target: $20 → $10
Current: $1.81
Upside: +452.49%
Corvus Pharmaceuticals
May 30, 2023
Maintains: Buy
Price Target: $4 → $10
Current: $1.78
Upside: +461.80%
Palisade Bio
May 16, 2023
Maintains: Buy
Price Target: $375 → $240
Current: $4.54
Upside: +5,186.34%
Tempest Therapeutics
Apr 28, 2023
Maintains: Buy
Price Target: $8 → $14
Current: $2.12
Upside: +560.38%
Processa Pharmaceuticals
Apr 4, 2023
Maintains: Speculative Buy
Price Target: $180 → $80
Current: $1.93
Upside: +4,045.08%
Adverum Biotechnologies
Mar 7, 2023
Initiates: Buy
Price Target: $20
Current: $6.84
Upside: +192.40%
NeuroBo Pharmaceuticals
Dec 7, 2022
Initiates: Buy
Price Target: $48
Current: $4.68
Upside: +925.64%
Calithera Biosciences
Nov 15, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.01
Upside: -
NextCure
Nov 4, 2022
Downgrades: Neutral
Price Target: n/a
Current: $1.50
Upside: -
Allarity Therapeutics
Aug 23, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.22
Upside: -
Anebulo Pharmaceuticals
Jul 27, 2022
Initiates: Buy
Price Target: $6
Current: $2.49
Upside: +140.96%
Nuvectis Pharma
Jul 13, 2022
Initiates: Buy
Price Target: $21
Current: $6.51
Upside: +222.58%
Quoin Pharmaceuticals
May 6, 2022
Initiates: Buy
Price Target: $300
Current: $0.58
Upside: +51,929.14%
Annovis Bio
May 2, 2022
Initiates: Buy
Price Target: $37
Current: $9.28
Upside: +298.71%
Compass Therapeutics
Mar 15, 2022
Initiates: Buy
Price Target: $7
Current: $0.88
Upside: +695.45%
Nektar Therapeutics
Nov 8, 2021
Upgrades: Buy
Price Target: n/a
Current: $1.17
Upside: -
Regeneron Pharmaceuticals
Nov 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $1,044.66
Upside: -
Incyte
Jul 20, 2021
Upgrades: Buy
Price Target: n/a
Current: $59.02
Upside: -
Scopus BioPharma
Feb 16, 2021
Initiates: Speculative Buy
Price Target: n/a
Current: $0.00
Upside: -
Neurocrine Biosciences
Sep 30, 2020
Initiates: Hold
Price Target: n/a
Current: $137.49
Upside: -
Salarius Pharmaceuticals
Jun 16, 2020
Initiates: Speculative Buy
Price Target: $1,000
Current: $2.20
Upside: +45,354.55%
Inovio Pharmaceuticals
May 21, 2020
Initiates: Buy
Price Target: $336
Current: $8.43
Upside: +3,885.77%
Voyager Therapeutics
Mar 19, 2020
Initiates: Buy
Price Target: n/a
Current: $7.59
Upside: -